Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Pfizer appoints two senior roles

May 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, Read

Pfizer has named Olivier Brandicourt as president and general manager of its Emerging Markets and Established Products Business Units, and …
Appointment

Boehringer’s COPD drug passes hurdle

May 23, 2012 Research and Development, Sales and Marketing Boehringer, COPD, Daxas, Relovair, Spiriva, olodaterol

Boehringer Ingelheim’s once-daily bronchodilator olodaterol has improved lung function versus placebo in a Phase II trial.  The manufacturer wants the …
News
Doctor laptop image

Medical education: pharma’s evolving relationship with healthcare professionals

May 23, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Conference, InPharm, MEP, medical education

There are at least two perspectives of what ‘Medical Education’ means, and certainly many definitions.For doctors and other healthcare professionals, …
Feature

AMRI announces president for AMRI Europe

May 23, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AMRI, AMRI Europe, CMO

Contract research and manufacturing organisation AMRI has announced the appointment of Ian Shott as president of AMRI Europe.  In this …
Appointment
oliver_leatham

MSI appoints new market access consultant

May 22, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, appointment, market access

Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant. Oliver has a wide experience as …
Appointment

Pharma R&D model no help to developing countries

May 22, 2012 Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D

Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …
News

UCB signs new epilepsy research pact with Imperial

May 21, 2012 Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …
News

ICON makes two senior appointments

May 21, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRO, ICON, appointment

ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …
Appointment

GSK buys more of Theravance

May 18, 2012 Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …
News
screen_shot_2012-05-18_at_09

Teva re-elects Chairman of the Board

May 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frost, Teva

Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …
Appointment

Medivir appoints commercial executive vice president

May 17, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Juserius, Medivir

Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company’s commercial activities.  Juserius who …
Appointment
Nexavar image

Torisel fails in head-to-head study with Nexavar

May 16, 2012 Research and Development, Sales and Marketing Bayer, Nexavar, Pfizer, Torisel, inlyta, rcc

Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial.  The Phase III study was …
News

Pharma funds drug discovery partnership

May 16, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dundee, MRC, drug discovery, funding, partnerships, pharma

Half a dozen pharma firms are contributing £14.4 million to work by Dundee University and the Medical Research Council (MRC) on …
News
Erbitux image

Merck KGaA’s colon cancer drug fails trial

May 16, 2012 Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer

Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial.  …
News

Capturing the Brazilian pharma opportunity

May 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025